{"id":55256,"date":"2024-01-14T09:11:30","date_gmt":"2024-01-14T09:11:30","guid":{"rendered":"https:\/\/medsname.com\/nimodip-nimodipine\/"},"modified":"2026-05-01T10:49:12","modified_gmt":"2026-05-01T10:49:12","slug":"nimodip-nimodipine","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/nimodip-nimodipine\/","title":{"rendered":"Nimodip (Nimodipin\u0103)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Nimodip?<\/h3>\n<p style=\"margin:0;\"><strong>Nimodip<\/strong> este un <strong>comprimat de 30 mg nimodipin\u0103<\/strong> de la un produc\u0103tor certificat WHO-GMP \u2014 un blocant al canalelor de calciu (BCC) dihidropiridinic cu activitate cerebrovascular\u0103 selectiv\u0103. Introdus \u00een 1989 (Bayer sub denumirea <strong>Nimotop<\/strong>) special pentru utilizare neurochirurgical\u0103. Spre deosebire de alte dihidropiridine, nimodipina are o lipofilitate ridicat\u0103 care \u00eei permite s\u0103 treac\u0103 bariera hemato-encefalic\u0103 \u0219i s\u0103 ac\u021bioneze preferen\u021bial pe mu\u0219chiul net arterial cerebral. Timpul de \u00eenjum\u0103t\u0103\u021bire plasmatic 1-2 ore (scurt) \u2014 necesit\u0103 administrare la 4 ore. Nimodipina NU este un antihipertensiv general \u2014 este utilizat\u0103 specific pentru a <strong>preveni ischemia cerebral\u0103 \u00eent\u00e2rziat\u0103 (vasospasm) dup\u0103 hemoragia subarahnoid\u0103 aneurismal\u0103 (HSAa)<\/strong>. Doz\u0103: 60 mg pe cale oral\u0103 la fiecare 4 ore timp de 21 de zile, \u00eencep\u00e2nd \u00een primele 96 de ore de la hemoragie. Pentru hipertensiune, utiliza\u021bi <a href=\"https:\/\/medsbase.com\/ro\/amlode\/\">amlodipine<\/a> sau <a href=\"https:\/\/medsbase.com\/ro\/nicardia-retard\/\">nifedipin\u0103 cu eliberare prelungit\u0103<\/a> \u00een schimb.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Nimodip?<\/h2>\n<p>Nimodip este un comprimat oral de 30 mg nimodipin\u0103 de la un produc\u0103tor certificat WHO-GMP, furnizat \u00een cutii de 30-180 de comprimate. Introdus \u00een 1989 (Bayer sub denumirea <strong>Nimotop<\/strong>) special pentru utilizare neurochirurgical\u0103. Spre deosebire de alte dihidropiridine, nimodipina are o lipofilitate ridicat\u0103 care \u00eei permite s\u0103 treac\u0103 bariera hemato-encefalic\u0103 \u0219i s\u0103 ac\u021bioneze preferen\u021bial pe mu\u0219chiul net arterial cerebral.<\/p>\n<p>Nimodipina apar\u021bine clasei <strong>blocan\u021bilor dihidropiridinici ai canalelor de calciu<\/strong> diferit\u0103 de non-dihidropiridinele (<a href=\"https:\/\/medsbase.com\/ro\/dilzem\/\">diltiazem<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/calaptin-40\/\">verapamil<\/a>) prin ac\u021biunea sa <strong>selectiv\u0103 asupra mu\u0219chilor netezi vasculari, cu un efect cardiac direct minim<\/strong>. Acest profil de selectivitate este important din punct de vedere clinic: DHPs pot fi combinate \u00een siguran\u021b\u0103 cu beta-blocante (combina\u021bia este standard \u00een angina pectoris), \u00een timp ce non-DHPs nu pot (risc adi\u021bional de bradicardie\/bloc cardiac).<\/p>\n<h2 class=\"wp-block-heading\">Cum ac\u021bioneaz\u0103 nimodipina<\/h2>\n<p>Blocatorii canalelor de calciu se leag\u0103 de canalele de calciu tip L dependente de voltaj \u0219i reduc intrarea de calciu \u00een celul\u0103 \u00een timpul depolariz\u0103rii. \u00cen <strong>mu\u0219chiul neted arterial<\/strong>, reducerea intr\u0103rii de calciu \u00eenseamn\u0103 o interac\u021biune actin-miozin\u0103 mai mic\u0103 \u0219i <strong>vasodilata\u021bie arterial\u0103 direct\u0103<\/strong> \u2014 sc\u0103z\u00e2nd rezisten\u021ba vascular\u0103 sistemic\u0103 \u0219i tensiunea arterial\u0103.<\/p>\n<p>Dihidropiridinele sunt de ~10 ori mai potente pe mu\u0219chiul net vascular dec\u00e2t pe mu\u0219chiul cardiac \u2014 astfel \u00eenc\u00e2t efectul clinic dominant este vasodilata\u021bia, cu o suprresie minim\u0103 direct\u0103 a contractilit\u0103\u021bii sau conduc\u021biei cardiace. Baroreflexul corpului poate declan\u0219a o u\u0219oar\u0103 tahicardie reflex\u0103 dup\u0103 vasodilata\u021bie rapid\u0103; nimodipina ac\u021bioneaz\u0103 central pe arterele cerebrale, astfel \u00eenc\u00e2t efectele reflexe sunt mai pu\u021bin relevante clinic.<\/p>\n<p>Declan\u0219area efectului clinic: rapid\u0103 (15-30 minute); concentra\u021bia plasmatic\u0103 maxim\u0103 \u00een 1 or\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri aprobate \u0219i bazate pe dovezi<\/h2>\n<ul>\n<li><strong>Hemoragie subarahnoid\u0103 aneurismal\u0103 (HSAa)<\/strong> \u2014 preven\u021bia ischemiei cerebrale \u00eent\u00e2rziate cauzate de vasospasm cerebral. 60 mg la fiecare 4 ore timp de 21 de zile, \u00eencep\u00e2nd \u00een primele 96 de ore.<\/li>\n<li><strong>Alte forme de vasospasm cerebral<\/strong> \u2014 off-label (post-chirurgie neurologic\u0103, hemoragie subarahnoidian\u0103 traumatic\u0103)<\/li>\n<li><strong>Deteriorare cognitiv\u0103 vascular\u0103 \/ demen\u021b\u0103 u\u0219oar\u0103<\/strong> \u2014 off-label; dovezi variabile<\/li>\n<li><strong>Profilaxia migrenei<\/strong> \u2014 off-label; nu de prim\u0103 inten\u021bie<\/ul>\n<p><strong>Dovezile din studiile pivotale:<\/strong> <strong>British Aneurysm Nimodipine Trial (1989)<\/strong> \u0219i confirm\u0103rile ulterioare \u2014 nimodipina oral\u0103 60 mg la fiecare 4 ore timp de 21 de zile dup\u0103 hemoragia subarahnoidian\u0103 aneurismal\u0103 (aSAH) reduce inciden\u021ba ischemiei cerebrale \u00eent\u00e2rziate (cauzat\u0103 de vasospasm) \u0219i \u00eembun\u0103t\u0103\u021be\u0219te rezultatul neurologic. Aceasta r\u0103m\u00e2ne SINGURA interven\u021bie farmacologic\u0103 dovedit\u0103 pentru reducerea morbidit\u0103\u021bii legate de vasospasm \u00een aSAH.<\/p>\n<h2 class=\"wp-block-heading\">Doza de Nimodip<\/h2>\n<p><strong>Indica\u021bia principal\u0103 \u2014 preven\u021bia vasospasmului \u00een aSAH:<\/strong><\/p>\n<ul>\n<li><strong>60 mg pe cale oral\u0103 la fiecare 4 ore timp de 21 de zile<\/strong>, \u00eencep\u00e2nd \u00een primele 96 de ore de la diagnosticul hemoragiei subarahnoidiene<\/li>\n<li>La pacien\u021bi intuba\u021bi\/ incon\u0219tien\u021bi: aceea\u0219i doz\u0103 prin sond\u0103 nazogastric\u0103<\/li>\n<li>Reduce\u021bi la 30 mg la fiecare 4 ore \u00een cazul insuficien\u021bei hepatice<\/li>\n<li>Suspendare dac\u0103 tensiunea arterial\u0103 sistolic\u0103 scade sub 100 mmHg; \u00eenc\u0103rcarea volumic\u0103 agresiv\u0103 pentru men\u021binerea presiunii de perfuzie cerebral\u0103 este tipic\u0103 \u00een unit\u0103\u021bile de neurochirurgie<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Frecvente (&gt;5%, \u00een mare parte u\u0219oare \u0219i tranzitorii):<\/strong><\/p>\n<ul>\n<li>Hipotensiune (principala preocupare \u00een utilizarea neurochirurgical\u0103 acut\u0103)<\/li>\n<li>Rubor (febre facial\u0103 \u0219i a p\u0103r\u021bii superioare a corpului)<\/li>\n<li>Cefalee (\u00een special la \u00eenceputul terapiei; de obicei se atenueaz\u0103 \u00een 2-4 s\u0103pt\u0103m\u00e2ni)<\/li>\n<li>Tahicardie reflex\u0103 (palpita\u021bii) \u2014 mai pu\u021bin frecvent\u0103 la formul\u0103rile cu eliberare prelungit\u0103<\/li>\n<li>Ame\u021beli, hipotensiune postural\u0103<\/li>\n<li>Oboseal\u0103<\/li>\n<li>Constipa\u021bie u\u0219oar\u0103 (mai pu\u021bin frecvent\u0103 dec\u00e2t la CCB non-DHP)<\/li>\n<\/ul>\n<p><strong>Mai pu\u021bin frecvente:<\/strong><\/p>\n<ul>\n<li>Erup\u021bie cutanat\u0103, prurit<\/li>\n<li>Grea\u021b\u0103, disconfort abdominal<\/li>\n<li>Disfunc\u021bie erectil\u0103 (rar\u0103)<\/li>\n<li>Cre\u0219teri ale enzimelor hepatice (de obicei u\u0219oare, reversibile)<\/li>\n<li>Rapoarte rare de fotosensibilitate<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii \u0219i precau\u021bii<\/h2>\n<ul>\n<li>Hipersensibilitate cunoscut\u0103 la nimodipin\u0103 sau la clasa dihidropiridinelor<\/li>\n<li>\u0218oc cardiogen<\/li>\n<li>Stenoaz\u0103 aortic\u0103 sever\u0103 (poate provoca hipotensiune critic\u0103)<\/li>\n<li>Angin\u0103 instabil\u0103 sau infarct miocardic \u00een ultima lun\u0103 (DHP-uri \u00een afar\u0103 de amlodipin\u0103)<\/li>\n<li>Cardiomiopatie hipertrofic\u0103 obstructiv\u0103 (reduce gradientul de ejectie dinamic)<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103 (toate DHP-urile sunt metabolizate hepatic)<\/li>\n<\/ul>\n<p><strong>Sarcina:<\/strong> Evita\u021bi nimodipina, cu excep\u021bia cazurilor \u00een care este absolut necesar\u0103 pentru hemoragia subarahnoid\u0103 aneurismatic\u0103 (aSAH) (unde beneficiul dep\u0103\u0219e\u0219te riscul).<\/p>\n<p><strong>Al\u0103ptarea:<\/strong> cantit\u0103\u021bi mici \u00een laptele matern; considerat\u0103 \u00een general acceptabil\u0103 cu monitorizarea sugarului.<\/p>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Suc de grapefruit<\/strong> \u2014 inhib\u0103 metabolismul CYP3A4; poate cre\u0219te nivelul plasmatic al amlodipinei \u0219i \u00een special al nifedipinei\/nimodipinei de 2-3 ori. Evita\u021bi \u00een zilele de tratament sau folosi\u021bi consecvent dac\u0103 este cazul.<\/li>\n<li><strong>Inhibitori puternici ai CYP3A4<\/strong> (ketoconazol, itraconazol, claritromicin\u0103, ritonavir, cobicistat) \u2014 cresc nivelurile plasmatice ale BCC; reduce\u021bi doza sau evita\u021bi<\/li>\n<li><strong>Inductori puternici ai CYP3A4<\/strong> (rifampicin\u0103, fenitoin\u0103, carbamazepin\u0103, iarba Sf\u00e2ntului Ioan) \u2014 reduc nivelurile plasmatice ale BCC; poate fi necesar\u0103 cre\u0219terea dozei<\/li>\n<li><strong>Simvastatin\u0103<\/strong> \u2014 amlodipina cre\u0219te moderat expunerea la simvastatin\u0103; limita\u021bi simvastatina la 20 mg\/zi \u00een combina\u021bie<\/li>\n<li><strong>Beta-blocante<\/strong> \u2014 DHP-urile se combin\u0103 <strong>\u00een siguran\u021b\u0103<\/strong> cu beta-blocante (combina\u021bia este standard \u00een angina pectoral\u0103 \u2014 beta-blocantul atenueaz\u0103 tahicardia reflex\u0103, iar BCC ofer\u0103 vasodilata\u021bie). Distinct de BCC non-DHP (diltiazem, verapamil) care NU trebuie combinate cu beta-blocante.<\/li>\n<li><strong>Alte antihipertensive<\/strong> \u2014 \u00een general complementare; monitoriza\u021bi TA<\/li>\n<li><strong>Sildenafil \/ tadalafil<\/strong> (inhibitori PDE5 pentru disfunc\u021bie erectil\u0103) \u2014 hipotensiune aditiv\u0103; precau\u021bie mai ales la doze mari de BCC<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Clasa Blocatoarelor de Canale de Calciu pe scurt<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">BCC<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Clas\u0103<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Nis\u0103<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/amlode\/\">Amlodipin\u0103 (Amlode, Amlip)<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">DHP (genera\u021bia a 3-a)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">BCC de referin\u021b\u0103; o dat\u0103 pe zi pentru HTA + angin\u0103; dovezi din studiul ASCOT<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/depin\/\">Nifedipin\u0103 (Depin, Nicardia Retard, Cardipin)<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">DHP (genera\u021bia 1-a)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Sigur \u00een sarcin\u0103 cu formulare cu eliberare modificat\u0103; tocoliz\u0103; trebuie utilizate formulare cu eliberare prelungit\u0103 pentru HTA cronic\u0103<\/td>\n<\/tr>\n<tr style=\"background:#fff3cd;\">\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/nimodip-nimodipine\/\">Nimodipin\u0103 (Nimodip)<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">DHP (cerebrovascular)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prevenirea vasospasmului \u00een hemoragia subarahnoidian\u0103 \u2014 NU pentru hipertensiune arterial\u0103 de rutin\u0103<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/dilzem\/\">Diltiazem (Dilzem, Dilzem CD)<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Non-DHP (benzotiazepin\u0103)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Hipertensiune + controlul frecven\u021bei cardiace + angin\u0103; efect cardiac moderat<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/calaptin-40\/\">Verapamil (Calaptin 40, Calaptin SR)<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Non-DHP (fenilalchilamin\u0103)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Cel mai puternic efect cardiac; tahicardie supraventricular\u0103, controlul frecven\u021bei \u00een fibrila\u021bia atrial\u0103, cefalee \u00een cluster<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>DHP vs non-DHP \u2014 de ce conteaz\u0103:<\/strong> DHP-urile (amlodipina, nifedipina) ac\u021bioneaz\u0103 selectiv pe mu\u0219chiul neted arterial cu efect cardiac minimal \u2014 pot fi combinate \u00een siguran\u021b\u0103 cu beta-blocante. Non-DHP-urile (diltiazemul, verapamilul) \u00eencetinesc conduc\u021bia nodal\u0103 AV \u0219i reduc contractilitatea cardiac\u0103 \u2014 <strong>NU combina\u021bi cu beta-blocante<\/strong> (risc aditiv de bradicardie, bloc cardiac, insuficien\u021b\u0103 cardiac\u0103 acut\u0103). Dac\u0103 pacientul dumneavoastr\u0103 ia deja un beta-blocant, utiliza\u021bi un DHP.<\/p>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Nimodip sub 25\u00b0C. Proteja\u021bi de lumin\u0103. Depozita\u021bi \u00eentr-un loc inaccesibil copiilor.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Pot s\u0103 m\u0103n\u00e2nc grapefruit \u00een timp ce iau Nimodip?<\/h3>\n<p>Grapefruitul (sucul \u0219i fructul proasp\u0103t) inhib\u0103 metabolismul CYP3A4 \u0219i poate cre\u0219te nivelurile plasmatice ale nimodipinei de 2-3 ori, cresc\u00e2nd riscul de hipotensiune, ame\u021beli \u0219i edem. Cel mai bine: evita\u021bi grapefruitul\/sucul \u00een timpul tratamentului cu antagoni\u0219ti ai canalelor de calciu (CCB), sau consuma\u021bi-l constant (doza este ajustat\u0103 \u00een func\u021bie de r\u0103spunsul tensional; consumul sporadic de grapefruit perturb\u0103 acest echilibru).<\/p>\n<h3 class=\"wp-block-heading\">Este Nimodip sigur \u00een timpul sarcinii?<\/h3>\n<p>Nimodipina este evitat\u0103 \u00een timpul sarcinii, cu excep\u021bia cazurilor de hemoragie subarahnoid\u0103 aneurismatic\u0103 (aSAH) care pune via\u021ba \u00een pericol, unde beneficiul neurologic dep\u0103\u0219e\u0219te riscul expunerii fetale.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 combin Nimodip cu alte medicamente pentru tensiune arterial\u0103?<\/h3>\n<p>Da \u2014 BCC de tip DHP se combin\u0103 bine cu <strong>Inhibitori ACE<\/strong> (<a href=\"https:\/\/medsbase.com\/ro\/ramcor\/\">ramipril<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/lispro\/\">lisinopril<\/a>), <strong>BRA<\/strong> (<a href=\"https:\/\/medsbase.com\/ro\/losar\/\">losartan<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/telmaheal\/\">telmisartan<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/olmin\/\">olmesartan<\/a>), <strong>beta-blocante<\/strong> (<a href=\"https:\/\/medsbase.com\/ro\/concor\/\">bisoprolol<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/betablock-xl\/\">metoprolol<\/a>), \u0219i <strong>diuretice tiazidice<\/strong> (<a href=\"https:\/\/medsbase.com\/ro\/aquazide\/\">HCTZ<\/a>). Combina\u021bia ACEi\/ARB + CCB este deosebit de util\u0103 deoarece elimin\u0103 efectul secundar de edem la nivelul gleznelor.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 folosesc nimodipin\u0103 pentru hipertensiune arterial\u0103 obi\u0219nuit\u0103?<\/h3>\n<p>Nu \u2014 nimodipina este un blocant al canalelor de calciu specializat pentru neurochirurgie, utilizat \u00een cursuri de 21 de zile pentru a preveni vasospasmul cerebral dup\u0103 hemoragie subarahnoid\u0103. Scurtul s\u0103u timp de \u00eenjum\u0103t\u0103\u021bire necesit\u0103 administrare la fiecare 4 ore, ceea ce este impractic pentru hipertensiunea cronic\u0103, iar selectivitatea sa cerebrovascular\u0103 o face mai pu\u021bin eficient\u0103 \u00een controlul tensiunii arteriale periferice dec\u00e2t amlodipina sau nifedipina MR. Utiliza\u021bi <a href=\"https:\/\/medsbase.com\/ro\/amlode\/\">amlodipine<\/a> sau <a href=\"https:\/\/medsbase.com\/ro\/nicardia-retard\/\">nifedipin\u0103 cu eliberare prelungit\u0103<\/a> pentru HTN cronic\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Nimodip online?<\/h3>\n<p>Pute\u021bi cump\u0103ra Nimodip (nimodipin\u0103 30 mg, 30-180 comprimate) de la MedsBase cu ambalaj discret \u0219i livrare la nivel mondial.<\/p>\n<h2 class=\"wp-block-heading\">Antihipertensive \u00eenrudite pe MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/aquazide\/\">Aquazide \u2014 Diuretic hidroclorotiazidic<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/calaptin-sr\/\">Calaptin SR \u2014 Verapamil SR 120\/240 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cardipin-retard\/\">Cardipin Retard \u2014 Nifedipin\u0103 20 mg ER<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/dilzem\/\">Dilzem \u2014 Diltiazem IR 30\/60 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/dilzem-cd\/\">Dilzem CD \u2014 Diltiazem CD 120\/180 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/nicardia-retard\/\">Nicardia Retard \u2014 Nifedipin\u0103 retard 10\/20\/30 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/high-blood-pressure-medication\/\"><strong>R\u0103sfoi\u021bi toate medicamentele pentru hipertensiune arterial\u0103<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui medic calificat. Hipertensiunea, insuficien\u021ba cardiac\u0103 \u0219i aritmiile necesit\u0103 diagnostic, monitorizare \u0219i individualizarea dozei de c\u0103tre un medic \u2014 utiliza\u021bi \u00eentotdeauna beta-blocante sub \u00eendrumare medical\u0103.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cerecetam\/\">Cerecetam<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/aquazide\/\">Aquazide<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/natrilix-sr\/\">Natrilix SR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/avil-25\/\">Avil 25<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tamoxilon\/\">Tamoxilon<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Nimodip este comprimate de nimodipin\u0103 30 mg \u2014 un blocant al canalelor de calciu dihidropiridinic selectiv cerebrovascular. INDICA\u021aIE PRINCIPAL\u0102: prevenirea ischemiei cerebrale \u00eent\u00e2rziate din cauza vasospasmului dup\u0103 hemoragia subarahnoid\u0103 aneurismal\u0103 (HSAa). Regim standard: 60 mg la fiecare 4 ore timp de 21 de zile, \u00eencep\u00e2nd \u00een primele 96 de ore dup\u0103 hemoragie (British Aneurysm Nimodipine Trial). Nu este destinat hipertensiunii arteriale obi\u0219nuite \u2014 utiliza\u021bi amlodipin\u0103 sau nifedipin\u0103 retard \u00een schimb.<\/p>","protected":false},"featured_media":55257,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3892,3893],"class_list":{"0":"post-55256","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-nimodip","11":"product_tag-nimodipine","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/55256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=55256"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/55257"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=55256"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=55256"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=55256"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=55256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}